v3.26.1
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis
The Company’s financial liabilities measured at fair value on a recurring basis and the level of inputs used for such measurements were as follows (in thousands):
As of
June 30,
2026
December 31,
2025
Level 3
Contingent liabilities$$166 
Schedule of the Changes In Fair Value of the Company’s Level 3 Financial Instruments
A summary of the changes in fair value of the Company’s Level 3 financial instruments for the six months ended June 30, 2026 and 2025 were as follows (in thousands):
Contingent
Liabilities
Balance at December 31, 2025$166 
Change in fair value included in other (expense) income, net
(166)
Balance at June 30, 2026$— 
Series D
Warrants
Common Stock
Warrants
Embedded Derivative
Liabilities
Contingent
Liabilities
Convertible DebtTotal
Balance at December 31, 2024$7,882 $10,976 $24,931 $— $— $43,789 
Additions— — — — 119,257 119,257 
Extinguishments— — (41,505)— (124,047)(165,552)
Change in fair value included in other (expense) income, net
(7,882)711 16,574 4,966 4,395 18,764 
Change in fair value included in interest income (expense), net— — — — 395 395 
Transfers out of Level 3— (11,687)— — — (11,687)
Balance at June 30, 2025$— $— $— $4,966 $— $4,966 
Schedule of Fair Value Measurement Inputs and Valuation Techniques
The range of assumptions used to calculate the fair value of the Series D Warrants, embedded derivative liabilities, contingent liabilities and convertible debt during the six months ended June 30, 2025 were as follows:
Series D WarrantsEmbedded
Derivative Liability
Contingent LiabilitiesConvertible
Debt
Interest rate-6.0%-6.0%
Risk-free rate4.2%
3.9% - 4.3%
3.7%
3.9% - 4.3%
Discount rate-40.0%-40.0%
Probability weight10.0%
1.3% - 75.0%
-
1.3% - 75.0%
Expected volatility65.0%65.0%61.0%65.0%
Expected term (years)0.8
0.3 - 2.0
1.8
0.3 - 2.0